AVE Science & Technology

Executive Summary

AVE Science & Technology is a Chinese biotech company dedicated to the research, development, and commercialization of innovative vaccines and biologics targeting infectious diseases. Founded in 2009 and headquartered in Beijing, the company leverages advanced biological platforms to address significant public health challenges. With a focus on preclinical-stage programs, AVE aims to build a robust pipeline from discovery through late-stage clinical development. Despite being a private entity with limited public financial disclosures, the company's emphasis on vaccine innovation positions it well within the rapidly evolving infectious disease landscape, particularly in China where demand for novel vaccines remains high. The company's progress and potential partnerships will be key to its future growth.

Upcoming Catalysts (preview)

• Q3 2026IND Submission for Lead Vaccine Candidate40% success